Personal information

Other IDs

Scopus Author ID: 57201458281

Activities

Collapse all

Works (25)

Clinical and Molecular Characteristics of High-Risk, Recurrent, or Metastatic Endometrial Cancer That Is Human Epidermal Growth Factor Receptor 2–Low

Journal of Clinical Oncology
2025-02 | Journal article
DOI: 10.1200/JCO.23.02768
Contributors: Dione van Dijk; Lisa Vermij; Alicia León-Castillo; Melanie Powell; Jan Jobsen; Alexandra Leary; David Bowes; Linda Mileshkin; Catherine Genestie; Ina Jürgenliemk-Schulz et al.
Source: check_circle
Crossref

Clinical Behavior and Molecular Landscape of Stage I p53-Abnormal Low-Grade Endometrioid Endometrial Carcinomas

Clinical Cancer Research
2023-12-01 | Journal article
DOI: 10.1158/1078-0432.CCR-23-1397
Contributors: Amy Jamieson; Lisa Vermij; Claire J.H. Kramer; Jan J. Jobsen; Ina Jürgemlienk-Schulz; Ludy Lutgens; Jan Willem Mens; Marie A.D. Haverkort; Annerie Slot; Remi A. Nout et al.
Source: check_circle
Crossref

Data from Clinical Behavior and Molecular Landscape of Stage I p53-Abnormal Low-Grade Endometrioid Endometrial Carcinomas

2023-12-01 | Preprint
DOI: 10.1158/1078-0432.c.6960656
Contributors: Amy Jamieson; Lisa Vermij; Claire J.H. Kramer; Jan J. Jobsen; Ina Jürgemlienk-Schulz; Ludy Lutgens; Jan Willem Mens; Marie A.D. Haverkort; Annerie Slot; Remi A. Nout et al.
Source: check_circle
Crossref

Data from Clinical Behavior and Molecular Landscape of Stage I p53-Abnormal Low-Grade Endometrioid Endometrial Carcinomas

2023-12-01 | Preprint
DOI: 10.1158/1078-0432.c.6960656.v1
Contributors: Amy Jamieson; Lisa Vermij; Claire J.H. Kramer; Jan J. Jobsen; Ina Jürgemlienk-Schulz; Ludy Lutgens; Jan Willem Mens; Marie A.D. Haverkort; Annerie Slot; Remi A. Nout et al.
Source: check_circle
Crossref

Supplementary Figure S1 from Clinical Behavior and Molecular Landscape of Stage I p53-Abnormal Low-Grade Endometrioid Endometrial Carcinomas

2023-12-01 | Preprint
DOI: 10.1158/1078-0432.24710855
Contributors: Amy Jamieson; Lisa Vermij; Claire J.H. Kramer; Jan J. Jobsen; Ina Jürgemlienk-Schulz; Ludy Lutgens; Jan Willem Mens; Marie A.D. Haverkort; Annerie Slot; Remi A. Nout et al.
Source: check_circle
Crossref

Supplementary Figure S1 from Clinical Behavior and Molecular Landscape of Stage I p53-Abnormal Low-Grade Endometrioid Endometrial Carcinomas

2023-12-01 | Preprint
DOI: 10.1158/1078-0432.24710855.v1
Contributors: Amy Jamieson; Lisa Vermij; Claire J.H. Kramer; Jan J. Jobsen; Ina Jürgemlienk-Schulz; Ludy Lutgens; Jan Willem Mens; Marie A.D. Haverkort; Annerie Slot; Remi A. Nout et al.
Source: check_circle
Crossref

Supplementary Figure S2 from Clinical Behavior and Molecular Landscape of Stage I p53-Abnormal Low-Grade Endometrioid Endometrial Carcinomas

2023-12-01 | Preprint
DOI: 10.1158/1078-0432.24710852.v1
Contributors: Amy Jamieson; Lisa Vermij; Claire J.H. Kramer; Jan J. Jobsen; Ina Jürgemlienk-Schulz; Ludy Lutgens; Jan Willem Mens; Marie A.D. Haverkort; Annerie Slot; Remi A. Nout et al.
Source: check_circle
Crossref

Supplementary Figure S2 from Clinical Behavior and Molecular Landscape of Stage I p53-Abnormal Low-Grade Endometrioid Endometrial Carcinomas

2023-12-01 | Preprint
DOI: 10.1158/1078-0432.24710852
Contributors: Amy Jamieson; Lisa Vermij; Claire J.H. Kramer; Jan J. Jobsen; Ina Jürgemlienk-Schulz; Ludy Lutgens; Jan Willem Mens; Marie A.D. Haverkort; Annerie Slot; Remi A. Nout et al.
Source: check_circle
Crossref

Supplementary Figure S3 from Clinical Behavior and Molecular Landscape of Stage I p53-Abnormal Low-Grade Endometrioid Endometrial Carcinomas

2023-12-01 | Preprint
DOI: 10.1158/1078-0432.24710849.v1
Contributors: Amy Jamieson; Lisa Vermij; Claire J.H. Kramer; Jan J. Jobsen; Ina Jürgemlienk-Schulz; Ludy Lutgens; Jan Willem Mens; Marie A.D. Haverkort; Annerie Slot; Remi A. Nout et al.
Source: check_circle
Crossref

Supplementary Figure S3 from Clinical Behavior and Molecular Landscape of Stage I p53-Abnormal Low-Grade Endometrioid Endometrial Carcinomas

2023-12-01 | Preprint
DOI: 10.1158/1078-0432.24710849
Contributors: Amy Jamieson; Lisa Vermij; Claire J.H. Kramer; Jan J. Jobsen; Ina Jürgemlienk-Schulz; Ludy Lutgens; Jan Willem Mens; Marie A.D. Haverkort; Annerie Slot; Remi A. Nout et al.
Source: check_circle
Crossref

Supplementary Figure S4 from Clinical Behavior and Molecular Landscape of Stage I p53-Abnormal Low-Grade Endometrioid Endometrial Carcinomas

2023-12-01 | Preprint
DOI: 10.1158/1078-0432.24710843
Contributors: Amy Jamieson; Lisa Vermij; Claire J.H. Kramer; Jan J. Jobsen; Ina Jürgemlienk-Schulz; Ludy Lutgens; Jan Willem Mens; Marie A.D. Haverkort; Annerie Slot; Remi A. Nout et al.
Source: check_circle
Crossref

Supplementary Figure S4 from Clinical Behavior and Molecular Landscape of Stage I p53-Abnormal Low-Grade Endometrioid Endometrial Carcinomas

2023-12-01 | Preprint
DOI: 10.1158/1078-0432.24710843.v1
Contributors: Amy Jamieson; Lisa Vermij; Claire J.H. Kramer; Jan J. Jobsen; Ina Jürgemlienk-Schulz; Ludy Lutgens; Jan Willem Mens; Marie A.D. Haverkort; Annerie Slot; Remi A. Nout et al.
Source: check_circle
Crossref

Supplementary Figure S5 from Clinical Behavior and Molecular Landscape of Stage I p53-Abnormal Low-Grade Endometrioid Endometrial Carcinomas

2023-12-01 | Preprint
DOI: 10.1158/1078-0432.24710840.v1
Contributors: Amy Jamieson; Lisa Vermij; Claire J.H. Kramer; Jan J. Jobsen; Ina Jürgemlienk-Schulz; Ludy Lutgens; Jan Willem Mens; Marie A.D. Haverkort; Annerie Slot; Remi A. Nout et al.
Source: check_circle
Crossref

Supplementary Figure S5 from Clinical Behavior and Molecular Landscape of Stage I p53-Abnormal Low-Grade Endometrioid Endometrial Carcinomas

2023-12-01 | Preprint
DOI: 10.1158/1078-0432.24710840
Contributors: Amy Jamieson; Lisa Vermij; Claire J.H. Kramer; Jan J. Jobsen; Ina Jürgemlienk-Schulz; Ludy Lutgens; Jan Willem Mens; Marie A.D. Haverkort; Annerie Slot; Remi A. Nout et al.
Source: check_circle
Crossref

Supplementary Material and Methods S1 from Clinical Behavior and Molecular Landscape of Stage I p53-Abnormal Low-Grade Endometrioid Endometrial Carcinomas

2023-12-01 | Preprint
DOI: 10.1158/1078-0432.24710837.v1
Contributors: Amy Jamieson; Lisa Vermij; Claire J.H. Kramer; Jan J. Jobsen; Ina Jürgemlienk-Schulz; Ludy Lutgens; Jan Willem Mens; Marie A.D. Haverkort; Annerie Slot; Remi A. Nout et al.
Source: check_circle
Crossref

Supplementary Material and Methods S1 from Clinical Behavior and Molecular Landscape of Stage I p53-Abnormal Low-Grade Endometrioid Endometrial Carcinomas

2023-12-01 | Preprint
DOI: 10.1158/1078-0432.24710837
Contributors: Amy Jamieson; Lisa Vermij; Claire J.H. Kramer; Jan J. Jobsen; Ina Jürgemlienk-Schulz; Ludy Lutgens; Jan Willem Mens; Marie A.D. Haverkort; Annerie Slot; Remi A. Nout et al.
Source: check_circle
Crossref

QPOLE: A Quick, Simple, and Cheap Alternative for POLE Sequencing in Endometrial Cancer by Multiplex Genotyping Quantitative Polymerase Chain Reaction

JCO Global Oncology
2023-05 | Journal article
DOI: 10.1200/GO.22.00384
Contributors: Anne Sophie V.M. Van den Heerik; Natalja T. Ter Haar; Lisa Vermij; Jan J. Jobsen; Mariel Brinkhuis; Suzan M. Roothaan; Alicia Leon-Castillo; Gitte Ortoft; Estrid Hogdall; Claus Hogdall et al.
Source: check_circle
Crossref

Prognostic refinement of NSMP high-risk endometrial cancers using oestrogen receptor immunohistochemistry

British Journal of Cancer
2023-03-30 | Journal article
DOI: 10.1038/s41416-023-02141-0
Contributors: Lisa Vermij; Jan J. Jobsen; Alicia León-Castillo; Mariel Brinkhuis; Suzan Roothaan; Melanie E. Powell; Stephanie M. de Boer; Pearly Khaw; Linda R. Mileshkin; Anthony Fyles et al.
Source: check_circle
Crossref

p53 immunohistochemistry in endometrial cancer: clinical and molecular correlates in the PORTEC-3 trial

Modern Pathology
2022-10 | Journal article
DOI: 10.1038/s41379-022-01102-x
Contributors: Lisa Vermij; Alicia Léon-Castillo; Naveena Singh; Melanie E. Powell; Richard J. Edmondson; Catherine Genestie; Pearly Khaw; Jan Pyman; C. Meg McLachlin; Prafull Ghatage et al.
Source: check_circle
Crossref

Prognostic refinement of NSMP high-risk endometrial cancers using oestrogen receptor immunohistochemistry

2022-09-14 | Preprint
DOI: 10.1101/2022.09.13.22279853
Contributors: Lisa Vermij; Jan J. Jobsen; Alicia León-Castillo; Mariel Brinkhuis; Suzan Roothaan; Melanie E. Powell; Stephanie M. de Boer; Pearly Khaw; Linda R. Mileshkin; Anthony Fyles et al.
Source: check_circle
Crossref

Performance of a HER2 testing algorithm specific for p53‐abnormal endometrial cancer

Histopathology
2021-10 | Journal article
DOI: 10.1111/his.14381
Contributors: Lisa Vermij; Naveena Singh; Alicia Leon‐Castillo; Nanda Horeweg; Jan Oosting; Joseph Carlson; Vincent Smit; Blake Gilks; Tjalling Bosse
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Prevalence and Prognosis of Lynch Syndrome and Sporadic Mismatch Repair Deficiency in Endometrial Cancer

JNCI: Journal of the National Cancer Institute
2021-09-04 | Journal article
DOI: 10.1093/jnci/djab029
Contributors: Cathalijne C B Post; Ellen Stelloo; Vincent T H B M Smit; Dina Ruano; Carli M Tops; Lisa Vermij; Tessa A Rutten; Ina M Jürgenliemk-Schulz; Ludy C H W Lutgens; Jan J Jobsen et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

HER2 Status in High-Risk Endometrial Cancers (PORTEC-3): Relationship with Histotype, Molecular Classification, and Clinical Outcomes

Cancers
2020-12-25 | Journal article
DOI: 10.3390/cancers13010044
Contributors: Lisa Vermij; Nanda Horeweg; Alicia Leon-Castillo; Tessa A. Rutten; Linda R. Mileshkin; Helen J. Mackay; Alexandra Leary; Melanie E. Powell; Naveena Singh; Emma J. Crosbie et al.
Source: check_circle
Crossref
grade
Preferred source (of 3)‎

Incorporation of molecular characteristics into endometrial cancer management

Histopathology
2020-01 | Journal article
DOI: 10.1111/his.14015
Contributors: Lisa Vermij; Vincent Smit; Remi Nout; Tjalling Bosse
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

ABO incompatibility and RhIG immunoprophylaxis protect against non-D alloimmunization by pregnancy

Transfusion
2018 | Journal article
DOI: 10.1111/trf.14606
EID:

2-s2.0-85044978527

Part of ISSN: 15372995 00411132
Contributors: Zwiers, C.; Koelewijn, J.M.; Vermij, L.; van Sambeeck, J.; Oepkes, D.; de Haas, M.; van der Schoot, C.E.
Source: Self-asserted source
Lisa Vermij via Scopus - Elsevier
How many people are using ORCID?